Approval · Notice of Compliance 27292 · 2021
PERSERIS: Notice of Compliance 27292
Issued December 23, 2021
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 27292
- Date
- December 23, 2021
- Company
- Hls Therapeutics IncEtobicoke, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Change in the manufacturing process for the drug product
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PERSERIS | Not yet assigned | — |
Medicinal ingredients
- RISPERIDONE 90 MG per SYR
- RISPERIDONE 120 MG per SYR